Spero Therapeutics Inc (SPRO)
1.315
-0.02
(-1.13%)
USD |
NASDAQ |
Nov 12, 16:00
1.315
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Price: 1.315 for Nov. 12, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2024 | 1.33 | 1.34 | 1.29 | 1.315 | 170917.0 |
| Nov 11, 2024 | 1.32 | 1.34 | 1.31 | 1.33 | 208653.0 |
| Nov 08, 2024 | 1.31 | 1.32 | 1.28 | 1.32 | 220602.0 |
| Nov 07, 2024 | 1.30 | 1.33 | 1.284 | 1.31 | 184142.0 |
| Nov 06, 2024 | 1.30 | 1.335 | 1.28 | 1.31 | 197173.0 |
| Nov 05, 2024 | 1.26 | 1.33 | 1.250 | 1.31 | 305965.0 |
| Nov 04, 2024 | 1.16 | 1.30 | 1.14 | 1.29 | 317207.0 |
| Nov 01, 2024 | 1.21 | 1.21 | 1.13 | 1.18 | 841491.0 |
| Oct 31, 2024 | 1.24 | 1.275 | 1.160 | 1.23 | 878063.0 |
| Oct 30, 2024 | 1.04 | 1.30 | 1.01 | 1.29 | 2.284M |
| Oct 29, 2024 | 1.29 | 1.33 | 1.27 | 1.31 | 901117.0 |
| Oct 28, 2024 | 1.31 | 1.32 | 1.280 | 1.29 | 119861.0 |
| Oct 25, 2024 | 1.28 | 1.35 | 1.26 | 1.33 | 491171.0 |
| Oct 24, 2024 | 1.27 | 1.27 | 1.23 | 1.26 | 57588.00 |
| Oct 23, 2024 | 1.27 | 1.270 | 1.255 | 1.26 | 24368.00 |
| Oct 22, 2024 | 1.26 | 1.28 | 1.26 | 1.27 | 26603.00 |
| Oct 21, 2024 | 1.28 | 1.28 | 1.26 | 1.28 | 60561.00 |
| Oct 18, 2024 | 1.29 | 1.30 | 1.28 | 1.28 | 87151.00 |
| Oct 17, 2024 | 1.24 | 1.34 | 1.23 | 1.285 | 191871.0 |
| Oct 16, 2024 | 1.21 | 1.24 | 1.20 | 1.24 | 85855.00 |
| Oct 15, 2024 | 1.20 | 1.25 | 1.20 | 1.20 | 123546.0 |
| Oct 14, 2024 | 1.25 | 1.26 | 1.22 | 1.23 | 55124.00 |
| Oct 11, 2024 | 1.23 | 1.258 | 1.22 | 1.25 | 78206.00 |
| Oct 10, 2024 | 1.23 | 1.24 | 1.20 | 1.24 | 132770.0 |
| Oct 09, 2024 | 1.25 | 1.25 | 1.22 | 1.24 | 110155.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6801
Minimum
Aug 02 2022
22.07
Maximum
Dec 28 2020
7.195
Average
2.025
Median
Price Benchmarks
| Arbutus Biopharma Corp | 3.65 |
| Equillium Inc | 0.86 |
| NovaBay Pharmaceuticals Inc | 0.7801 |
| Palatin Technologies Inc | 1.20 |
| iBio Inc | 2.55 |
Price Related Metrics
| PE Ratio | 3.868 |
| PS Ratio | 0.6684 |
| Price to Book Value | 0.8829 |
| Earnings Yield | 25.86% |
| Market Cap | 71.07M |
| Operating PE Ratio | 3.378 |
| Normalized PE Ratio | 3.134 |